Both in Biotechnology
ProKidney vs Artiva Biotherapeutics
Over the past year PROK returned −34.3% and ARTV returned +140.8%; their daily moves had a correlation of 0.09.
PROK −34.3% ARTV +140.8%Growth of $1, one year, split-adjusted
| Metric | PROK | ARTV |
|---|---|---|
| Price | $1.63 | $7.03 |
| Market cap | $340.6M | $343.7M |
| Today | +1.24% | −0.28% |
| 1 month | −10.9% | −36.6% |
| 6 months | +0.6% | +29.0% |
| Year to date | −27.2% | +63.9% |
| 1 year | −34.5% | +137.5% |
| Revenue growth (YoY) | −32.1% | — |
| Gross margin | 100.0% | — |
| Net margin | −18948.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 416.3× | — |
| Net cash | $181.6M | $349.4M |
| Dividend yield | — | — |
| Volatility (60d) | 68.6% | 67.2% |
| Short % of float | 24.3% | 15.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).